Aireen diagnostic scope

2Q 2021

Diabetic retinopathy is a severe, sight-damaging complication of diabetes. Early diagnosis minimises the risk of fatal complications and sight loss. For this reason, everyone with diabetes should undergo an eye examination every year. Up to 70% of patients do not undergo regular examination, however. Aireen allows for fast, precise, pain-free and accessible eye screening for patients with diabetes.

In just 10 seconds, Aireen’s diabetic retinopathy screening assesses a retina image with high precision.

  • Sensitivity 99.1%, specificity 90.9%*
  • Result in less than 10 seconds
  • Certified and proven through clinical trials

* in detecting diabetic retinopathy compared to a consensual assessment from two retina specialists, verified on a sample of 1,143 images from actual clinics.

Age-related macular degeneration (AMD) is a disease of the retina and is the most common cause of sight loss amongst older people, occurring in over 8% of the population over 50.

Aireen AMD screening assesses an image of the retina in 10 seconds, and confirms or rejects the presence of disease symptoms.

Glaucoma is a disease which results in progressive damage to the optic nerve. Left untreated, glaucoma can result in blindness.

Across the world, around 1.5 to 2% of the population over 40 suffer from glaucoma-related optic nerve damage.

Aireen glaucoma screening assesses an image of the retina in 10 seconds, and with high precision detects changes in the image which indicate the suspected presence of the disease.

Our awards